Status:
ACTIVE_NOT_RECRUITING
CET- REM (Correlating ECT Response to EEG Markers)
Lead Sponsor:
Washington University School of Medicine
Conditions:
ECT
Treatment Resistant Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Single-center study to determine the relationship between changes in depression symptoms and electroencephalographic (EEG) patterns induced by electroconvulsive therapy (ECT)
Detailed Description
Electroconvulsive therapy (ECT) is an effective treatment for many psychiatric illnesses, including major depressive disorder. While effective, objective markers have not been developed to predict cli...
Eligibility Criteria
Inclusion
- Age 18 years or greater
- Referral for ECT index course for treatment-resistant depression (unipolar major depressive disorder or bipolar depression), major depressive disorder with psychotic symptoms, schizophrenia or schizoaffective being treated for a depressed episode, unspecified depression
Exclusion
- Schizophrenia or schizoaffective disorder not being treated for a depressed episode.
Key Trial Info
Start Date :
October 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2027
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04451135
Start Date
October 9 2020
End Date
June 1 2027
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine/Barnes-Jewish Hospital
St Louis, Missouri, United States, 63110